BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33649842)

  • 41. Recent Advances in the Surgical Management of Thyroid Cancer.
    Scheller B; Culié D; Poissonnet G; Dassonville O; D'Andréa G; Bozec A
    Curr Oncol; 2023 May; 30(5):4787-4804. PubMed ID: 37232819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
    Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
    PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up.
    Vassilopoulou-Sellin R; Goepfert H; Raney B; Schultz PN
    Head Neck; 1998 Sep; 20(6):549-55. PubMed ID: 9702543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
    Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
    Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
    Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of Differentiated Thyroid Cancer in Children: Focus on the American Thyroid Association Pediatric Guidelines.
    Parisi MT; Eslamy H; Mankoff D
    Semin Nucl Med; 2016 Mar; 46(2):147-64. PubMed ID: 26897719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thyroid carcinoma in children and adolescents: presentation, clinical course, and outcome of therapy in 23 children and adolescents in Northern Greece.
    Pazaitou-Panayiotou K; Kaprara A; Boudina M; Georgiou E; Drimonitis A; Vainas I; Raptou E; Galaktidou G
    Hormones (Athens); 2005; 4(4):213-20. PubMed ID: 16613819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer?
    Campennì A; Giovanella L; Siracusa M; Stipo ME; Alibrandi A; Cucinotta M; Ruggeri RM; Baldari S
    Thyroid; 2014 Nov; 24(11):1607-11. PubMed ID: 25089829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is outcome of differentiated thyroid carcinoma influenced by tumor stage at diagnosis?
    Clement SC; Kremer LC; Links TP; Mulder RL; Ronckers CM; van Eck-Smit BL; van Rijn RR; van der Pal HJ; Tissing WJ; Janssens GO; van den Heuvel-Eibrink MM; Neggers SJ; van Dijkum EJ; Peeters RP; van Santen HM
    Cancer Treat Rev; 2015 Jan; 41(1):9-16. PubMed ID: 25544598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features may help to identify children and adolescents with greatest risk for thyroid nodules.
    Allen N; Desai N; Song C; Yu J; Prasad U; Francis G
    J Endocrinol Invest; 2020 Jul; 43(7):925-934. PubMed ID: 31927747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiated thyroid cancer in children and adolescents.
    Farahati J; Parlowsky T; Mäder U; Reiners C; Bucsky P
    Langenbecks Arch Surg; 1998 Aug; 383(3-4):235-9. PubMed ID: 9776448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study.
    Klein Hesselink MS; Nies M; Bocca G; Brouwers AH; Burgerhof JG; van Dam EW; Havekes B; van den Heuvel-Eibrink MM; Corssmit EP; Kremer LC; Netea-Maier RT; van der Pal HJ; Peeters RP; Schmid KW; Smit JW; Williams GR; Plukker JT; Ronckers CM; van Santen HM; Tissing WJ; Links TP
    J Clin Endocrinol Metab; 2016 May; 101(5):2031-9. PubMed ID: 26963949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer.
    Giovanella L; Imperiali M; Trimboli P
    Sci Rep; 2017 Aug; 7(1):7359. PubMed ID: 28779086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
    Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Jain NK; Mostoufi-Moab S; Hawkes CP; Nelson ND; Surrey LF; Jones ZS; Adzick NS; Kazahaya K; Bauer AJ
    Thyroid; 2020 Jul; 30(7):1037-1043. PubMed ID: 31573414
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel.
    Alzahrani AS; Alswailem M; Alswailem AA; Al-Hindi H; Goljan E; Alsudairy N; Abouelhoda M
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer.
    Qiu ZL; Wei WJ; Sun ZK; Shen CT; Song HJ; Zhang XY; Zhang GQ; Chen XY; Luo QY
    Cell Physiol Biochem; 2018; 48(2):718-730. PubMed ID: 30025398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.